Evidence map›Paper›PMID 30079419›Full record

ArticleChemical communications (Cambridge, England)2018

HMGB1 binds to the KRAS promoter G-quadruplex: a new player in oncogene transcriptional regulation?

Jussara Amato, Thushara W Madanayake, Nunzia Iaccarino, Ettore Novellino, Antonio Randazzo, Laurence H Hurley, Bruno Pagano

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. G-quadruplex DNA: a novel target for drug design.Cellular and molecular life sciences : CMLS · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jussara AmatoDepartment of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy. bruno.pagano@unina.it.
Thushara W Madanayake
Nunzia Iaccarino
Ettore Novellino
Antonio Randazzo
Laurence H Hurley
Bruno Pagano
Naples Anesthesia & Physician Associates · USUniversity of Arizona · US

Funding

Targeting MYC promoter G-quadruplex for MYC inhibition by IndenoisoquinolinesR01CA177585 · NCI · UNIVERSITY OF ARIZONA · PI SINTIM, HERMAN O, YANG, DANZHOU · 2014 to 2025
$4.0M
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??R01CA153821 · NCI · UNIVERSITY OF ARIZONA · PI HURLEY, LAURENCE H., YANG, DANZHOU · 2010 to 2014
$1.9M
NCI NIH HHS R01 CA153821NCI NIH HHS R01 CA177585
6 · The paper itself

Abstract

This communication reports on a possible distinct role of HMGB1 protein. Biophysical studies revealed that HMGB1 binds and stabilizes the G-quadruplex of the KRAS promoter element that is responsible for most of the transcriptional activity. Biological data showed that inhibition of HMGB1 increases KRAS expression. These results suggest that HMGB1 could play a role in the gene transcriptional regulation via the functional recognition of the G-quadruplex.

Indexed as

G-QuadruplexesCell Line, TumorFluoresceinFluorescent DyesGene Expression RegulationHMGB1 ProteinHumansPromoter Regions, GeneticProtein BindingProto-Oncogene Proteins p21(ras)RNA, Small InterferingFluoresceinFluorescent DyesHMGB1 ProteinHMGB1 protein, humanKRAS protein, humanProto-Oncogene Proteins p21(ras)RNA, Small Interfering

Identifiers

PMID30079419
PMCPMC6234227
OpenAlexW2885289170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.